Complete Filing Data
Inception Growth Acquisition Ltd reported Stockholders Equity of -$2.01 million for FY2022.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Inception Growth Acquisition Ltd did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Net Income Loss | $130.1K | $640.1K | $475.5K | |
| General And Administrative Expense | $1.0M | $1.6M | $742.3K | |
| Income Tax Expense Benefit | $15.9K | $92.3K | $299.2K | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $146.0K | $732.4K | $774.7K | |
| Nonoperating Income Expense | $1.2M | $2.7M | $1.5M | |
| Comprehensive Income Net Of Tax | ||||
| Other Nonoperating Income Expense | $1.5M | |||
| Operating Income Loss | -$1.0M | -$2.0M | -$742.3K | |
| Deferred Revenue Noncurrent | $2.6M | |||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$267.9K | -$470.5K | -$128.4K | $814.00 | $134.1K | $128.0K | $62.3K | $220.1K | $35.0K | $342.2K | -$163.9K | -$217.9K | -$37.7K | -$52.5K | |
| General And Administrative Expense | $290.5K | $503.8K | $166.3K | $209.2K | $203.8K | $254.5K | $423.2K | $235.6K | $410.1K | $155.5K | $170.2K | $228.4K | $37.7K | $52.5K | |
| Income Tax Expense Benefit | -$22.2K | $39.4K | $38.1K | $125.9K | $121.2K | $228.1K | $118.1K | ||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$267.9K | -$470.5K | -$128.4K | -$21.4K | $173.5K | $166.1K | $188.2K | $341.3K | $263.1K | -$163.9K | -$217.9K | ||||
| Nonoperating Income Expense | $22.6K | $33.3K | $37.9K | $187.8K | $377.4K | $420.7K | $611.4K | $576.9K | $1.1M | $460.3K | |||||
| Comprehensive Income Net Of Tax | $62.3K | $220.1K | $183.7K | -$5.4K | -$37.7K | -$52.5K | |||||||||
| Other Nonoperating Income Expense | $611.4K | $576.9K | $1.1M | $615.9K | $6.2K | $10.5K | |||||||||
| Operating Income Loss | -$290.5K | -$503.8K | -$166.3K | -$209.2K | -$203.8K | -$254.5K | -$862.1K | ||||||||
| Deferred Revenue Noncurrent | $2.6M | $2.6M | $2.6M | $2.6M | $2.6M | $2.6M | |||||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax | $93.3K | $158.5K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Stockholders Equity | -$2.0M | -$965.9K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $680.8K | $1.4M | ||
| Temporary Equity Carrying Amount Attributable To Parent | $32.1M | $106.1M | $104.5M | |
| Retained Earnings Accumulated Deficit | -$4.2M | -$2.0M | -$1.3M | |
| Liabilities Current | $2.0M | $600.5K | $486.2K | |
| Liabilities And Stockholders Equity | $32.1M | $106.9M | $106.3M | |
| Liabilities | $4.3M | $2.9M | $3.1M | |
| Common Stock Value | $264.00 | $264.00 | $264.00 | |
| Assets Held In Trust Noncurrent | $32.1M | $106.1M | $104.5M | |
| Assets Current | $60.4K | $842.7K | $1.8M | |
| Assets | $32.1M | $106.9M | $106.3M | |
| Accrued Liabilities Current | $1.3M | $119.4K | $475.9K | |
| Temporary Equity Accretion To Redemption Value Adjustment | $2.0M | $2.6M | $1.5M | $13.5M |
| Taxes Payable Current | $391.5K | $299.2K | ||
| Cash | $60.4K | |||
| Temporary Equity Accretion To Redemption Value | $1.5M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$620.4K | -$684.4K | ||
| Other Assets Current | $404.8K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$56.1K | -$620.4K | ||
| Deferred Underwriting Compensation Non Current | $2.3M | $2.3M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | ||||
| Cash And Cash Equivalents At Carrying Value | $60.4K | |||
| Excise Tax Payable Attributable To Redemption Of Common Stock | ||||
| Cash Withdrawn From Of Trust Account | $583.3K | |||
| Common Stock Subject To Possible Redemption Shares | ||||
| Cash Withdrawn From Trust Account In Connection To Redemption | $30.4M | $76.6M | ||
| Deferred Underwriting Compensation | $2.3M | |||
| Marketable Securities Unrealized Gain Loss |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$7.1M | -$6.8M | -$6.6M | -$6.4M | -$5.8M | -$5.5M | -$4.8M | -$4.2M | -$4.0M | -$3.2M | -$2.6M | -$2.0M | -$1.7M | -$1.5M | -$65.2K | -$27.5K | $25.0K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $9.1K | $59.1K | $2.8K | $4.3K | $11.3K | $83.7K | $44.2K | $60.4K | $257.2K | $542.8K | $481.4K | $779.1K | $787.4K | $796.7K | |||||
| Temporary Equity Carrying Amount Attributable To Parent | $2.2M | $2.1M | $3.7M | $3.6M | $14.7M | $14.4M | $32.8M | $31.5M | $46.9M | $46.1M | $105.2M | $104.7M | $104.5M | ||||||
| Retained Earnings Accumulated Deficit | -$7.1M | -$6.8M | -$6.6M | -$6.4M | -$5.8M | -$5.5M | -$4.8M | -$4.3M | -$3.5M | -$2.9M | -$2.0M | -$1.9M | -$1.5M | ||||||
| Liabilities Current | $4.9M | $4.6M | $4.3M | $4.1M | $3.6M | $3.4M | $2.6M | $18.2M | $1.6M | $62.0M | $405.1K | $215.4K | $130.1K | ||||||
| Liabilities And Stockholders Equity | $2.3M | $2.3M | $3.7M | $3.6M | $14.7M | $14.5M | $32.8M | $47.9M | $47.5M | $107.8M | $106.2M | $105.8M | $105.7M | ||||||
| Liabilities | $7.2M | $6.9M | $6.6M | $6.4M | $5.9M | $5.6M | $4.9M | $20.8M | $4.1M | $64.6M | $3.0M | $2.8M | $2.7M | ||||||
| Common Stock Value | $264.00 | $264.00 | $264.00 | $264.00 | $264.00 | $264.00 | $264.00 | $264.00 | $264.00 | $264.00 | $264.00 | $264.00 | $264.00 | ||||||
| Assets Held In Trust Noncurrent | $2.2M | $2.1M | $3.7M | $3.6M | $14.7M | $14.4M | $32.8M | $47.6M | $46.9M | $107.2M | $105.2M | $104.7M | $104.5M | ||||||
| Assets Current | $64.7K | $116.6K | $2.8K | $4.3K | $31.5K | $136.7K | $44.2K | $274.7K | $618.3K | $582.6K | $1.0M | $1.1M | $1.2M | ||||||
| Assets | $2.3M | $2.3M | $3.7M | $3.6M | $14.7M | $14.5M | $32.8M | $47.9M | $47.5M | $107.8M | $106.2M | $105.8M | $105.7M | ||||||
| Accrued Liabilities Current | $1.9M | $2.2M | $1.9M | $1.8M | $1.5M | $1.4M | $1.3M | $994.9K | $682.1K | $855.5K | $234.4K | $97.1K | $54.1K | ||||||
| Temporary Equity Accretion To Redemption Value Adjustment | $337.8K | $627.4K | $720.7K | $711.4K | $809.5K | $473.7K | -$457.4K | -$164.7K | -$10.9K | ||||||||||
| Taxes Payable Current | $194.3K | $194.3K | $275.3K | $275.3K | $314.7K | $336.9K | $300.5K | $774.5K | $648.6K | $527.4K | |||||||||
| Cash | $59.1K | $2.8K | $4.3K | $11.3K | $796.7K | $1.4M | |||||||||||||
| Temporary Equity Accretion To Redemption Value | $71.5K | $720.7K | $711.4K | $809.5K | $473.7K | $457.4K | $164.7K | $10.9K | |||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$199.4K | -$568.5K | |||||||||||||||||
| Other Assets Current | $101.2K | $161.9K | $237.5K | $313.1K | $388.7K | ||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$1.5K | -$16.2K | -$199.4K | ||||||||||||||||
| Deferred Underwriting Compensation Non Current | $2.3M | $2.3M | $2.6M | ||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $779.1K | $787.4K | $796.7K | $1.4M | |||||||||||||||
| Cash And Cash Equivalents At Carrying Value | $59.1K | $2.8K | $4.3K | $11.3K | $796.7K | $1.4M | |||||||||||||
| Excise Tax Payable Attributable To Redemption Of Common Stock | $12.4K | $190.4K | $161.4K | ||||||||||||||||
| Cash Withdrawn From Of Trust Account | -$300.0K | ||||||||||||||||||
| Common Stock Subject To Possible Redemption Shares | 10.4M | 10.4M | 10.4M | ||||||||||||||||
| Cash Withdrawn From Trust Account In Connection To Redemption | |||||||||||||||||||
| Deferred Underwriting Compensation | $2.3M | $2.3M | $2.3M | $2.3M | $2.3M | ||||||||||||||
| Marketable Securities Unrealized Gain Loss | $93.3K | $158.5K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$912.9K | -$997.8K | -$856.0K |
| Net Cash Provided By Used In Financing Activities | -$28.7M | -$76.4M | $171.6K |
| Increase Decrease In Accrued Liabilities | $227.7K | $393.4K | -$356.5K |
| Proceeds From Repayments Of Related Party Debt | $217.9K | $104.2K | $171.6K |
| Increase Decrease In Accrued Income Taxes Payable | -$116.3K | $92.3K | $299.2K |
| Proceeds From Related Party Debt | $1.5M | $90.0K | |
| Net Cash Provided By Used In Investing Activities | $29.6M | $76.7M | |
| Increase Decrease In Prepaid Expense | -$161.9K | -$242.9K | |
| Payments For Repurchase Of Common Stock | $30.4M | $76.6M | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$242.9K | ||
| Proceeds From Issuance Of Common Stock | |||
| Payments For Proceeds From Investments | $400.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$60.1K | -$376.2K | -$217.5K | -$634.1K | -$52.5K | $10.0K |
| Net Cash Provided By Used In Financing Activities | $92.2K | $660.0K | $18.0K | $65.7K | $52.5K | -$10.0K |
| Increase Decrease In Accrued Liabilities | $106.2K | $7.5K | $131.9K | -$421.8K | $10.0K | |
| Proceeds From Repayments Of Related Party Debt | $92.2K | $30.0K | $18.0K | $65.7K | ||
| Increase Decrease In Accrued Income Taxes Payable | -$91.1K | $228.1K | ||||
| Proceeds From Related Party Debt | $630.0K | $65.7K | $27.5K | $95.0K | ||
| Net Cash Provided By Used In Investing Activities | -$33.6K | -$300.0K | ||||
| Increase Decrease In Prepaid Expense | -$60.7K | |||||
| Payments For Repurchase Of Common Stock | ||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$60.7K | -$16.1K | ||||
| Proceeds From Issuance Of Common Stock | $25.0K | $25.0K | ||||
| Payments For Proceeds From Investments |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2023 | FY2022 | FY2021 |
|---|---|---|---|
| Temporary Equity Redemption Price Per Share | $10.86 | $10.25 | $10.10 |
| Common Stock Shares Outstanding | 2.6M | 2.6M | 2.6M |
| Common Stock Shares Issued | 2.6M | 2.6M | 2.6M |
| Common Stock Shares Authorized | 26.0M | 26.0M | 26.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 |
| Earnings Per Share Diluted | $0.25 | $0.07 | |
| Earnings Per Share Basic | $0.25 | $0.07 | |
| Weighted Average Number Of Shares Outstanding Basic | 5.2M | 10.0M | |
| Weighted Average Number Of Diluted Shares Outstanding | 5.2M | 10.0M | |
| Temporary Equity Shares Outstanding | 3.0M | 10.4M | |
| Temporary Equity Shares Issued | 10.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Temporary Equity Redemption Price Per Share | $12.46 | $12.10 | $13.13 | $12.88 | $11.63 | $11.36 | $11.10 | $10.67 | $10.48 | $10.30 | $10.16 | $10.12 | $10.10 | ||
| Common Stock Shares Outstanding | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | ||
| Common Stock Shares Issued | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | ||
| Common Stock Shares Authorized | 26.0M | 26.0M | 26.0M | 26.0M | 26.0M | 26.0M | 26.0M | 26.0M | 26.0M | 26.0M | 26.0M | 26.0M | 26.0M | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Earnings Per Share Diluted | $0.10 | $0.07 | $0.10 | $0.05 | $0.04 | $-0.01 | $-0.02 | ||||||||
| Earnings Per Share Basic | $0.08 | $0.10 | $0.05 | $0.04 | $-0.01 | $-0.02 | $0.00 | ||||||||
| Weighted Average Number Of Shares Outstanding Basic | 4.1M | 4.5M | 9.2M | 10.4M | 10.0M | 10.4M | |||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 4.1M | 4.5M | 9.2M | 10.4M | 10.0M | 10.4M | |||||||||
| Temporary Equity Shares Outstanding | 176.7K | 176.7K | 280.0K | 280.0K | 1.3M | 3.0M | 3.0M | ||||||||
| Temporary Equity Shares Issued | 4.5M | 4.5M | 10.4M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Dividend Income Operating | $2.7M | $1.2M | ||
| Investment Income Interest And Dividend | $1.2M | $2.7M | $1.5M | |
| Accretion Of Carrying Value To Redemption Value | $2.6M | $1.5M | ||
| Prepaid Expense Current | $161.9K | |||
| Excise And Sales Taxes | $765.5K | |||
| Income Loss Attributable To Parent | ||||
| Investment Income Interest | $299.3K | |||
| Accretionof Carrying Valueto Redemption Value | $2.6M | $1.5M | ||
| Extension Payments Deposited In Trust Account | $811.2K | $400.0K | ||
| Unrealized Gain On Availableforsale Securities | ||||
| Contribution Nonredemption Agreement | $452.0K | |||
| Stock Issued1 | $304.2K | $765.5K | ||
| Other Operating Income Expense Net | ||||
| Nonredemption Agreement Expense | $452.0K | |||
| Due To Related Parties Current | $181.8K | $10.3K | ||
| Stock Issued During Period Value New Issues | ||||
| Reclassification Of Realized Gain On Availableforsale Securities Net To Net Income |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Income Operating | $611.4K | $576.9K | $1.1M | $316.6K | $6.2K | $10.5K | |||||||||
| Investment Income Interest And Dividend | $22.6K | $33.3K | $37.9K | $187.8K | $377.4K | $420.7K | $611.4K | $1.1M | $10.5K | ||||||
| Accretion Of Carrying Value To Redemption Value | $62.3K | -$300.0K | $71.5K | $337.8K | $627.4K | $720.7K | $473.7K | $10.9K | |||||||
| Prepaid Expense Current | $5.6K | $7.5K | $20.3K | $40.5K | $17.5K | $75.5K | |||||||||
| Excise And Sales Taxes | $190.4K | $161.4K | $604.1K | ||||||||||||
| Income Loss Attributable To Parent | $460.3K | -$163.9K | -$217.9K | -$37.7K | -$52.5K | ||||||||||
| Investment Income Interest | $299.3K | ||||||||||||||
| Accretionof Carrying Valueto Redemption Value | $62.3K | -$300.0K | $71.5K | $337.8K | $627.4K | $720.7K | $473.7K | $10.9K | |||||||
| Extension Payments Deposited In Trust Account | $33.6K | $300.0K | |||||||||||||
| Unrealized Gain On Availableforsale Securities | $93.3K | $158.5K | |||||||||||||
| Contribution Nonredemption Agreement | $452.0K | ||||||||||||||
| Stock Issued1 | |||||||||||||||
| Other Operating Income Expense Net | $615.9K | $6.2K | $10.5K | ||||||||||||
| Nonredemption Agreement Expense | $452.0K | ||||||||||||||
| Due To Related Parties Current | $170.7K | $118.3K | $76.0K | ||||||||||||
| Stock Issued During Period Value New Issues | $25.0K | ||||||||||||||
| Reclassification Of Realized Gain On Availableforsale Securities Net To Net Income | -$251.8K |
Most recent annual filing with the SEC: March 26, 2025
Data sourced from SEC EDGAR public filings as of August 5, 2026.